Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The feasibility and benefit of a brief psychosocial intervention in addition to early palliative care in patients with advanced cancer to reduce depressive symptoms: a pilot randomized controlled clinical trial

Fig. 2

Graphical longitudinal evaluation of the scores on baseline, days 45, 90, 120 and 180 according with the treatment arms. a: PHQ-9; b: HADS-depression; c: HADS-anxiety; d: ESAS-depression; e: ESAS-anxiety; f: ESAS-emotional; g: global health (quality of life); h: Emotional functioning. Blue line, arm A; red line, arm B; black line, arm C

Back to article page